Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
DRIO
Strong SellSinkerDarioHealth Corp. · Healthcare · United States · $66M · Avg Vol: $191K/d
COMPANY DESCRIPTION
DarioHealth Corp. is a leading global digital therapeutics company that offers a user-centric, multi-chronic condition management platform covering diabetes, hypertension, and musculoskeletal health. The company's competitive advantage lies in its highly engaging, AI-driven software platform that integrates biometric devices with personalized coaching to drive behavioral change. DarioHealth operates as a prominent player in the digital health and enterprise wellness sectors.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27.7M | 20.4M | 27.0M | 22.4M | -6.8% | 21.0M | 21.7M | 31.5M | 18.6% |
| EPS | -8.94 | -7.18 | -3.22 | -10.12 | — | -14.87 | — | — | — |
| Shares | 7.3M | 7.3M | 7.3M | 6.9M | -5.6% | — | — | — | — |
| Debt | 28.0M | 29.5M | 30.2M | 31.7M | 4.2% | 32.4M | — | — | — |
| Equity | 80.0M | 58.1M | 72.0M | 67.9M | -5.3% | — | — | — | — |
| Op CF | -47.8M | -30.4M | -38.6M | -25.9M | — | -25.3M | — | — | — |
| Inv CF | -0.6M | -0.5M | -8.9M | -4.3M | — | — | — | — | — |
| Fin CF | 61.9M | 18.3M | 38.5M | 24.3M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of DRIO are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| DRIO | DarioHealth Corp.(you) | $66M | 9 | Strong Sell |
| CHLT.TO | Custom Health Holdings Inc. | $135M | 11 | Strong Sell |
| M7T.AX | Mach7 Technologies Limited | $54M | 23 | Sell |
| LFMD | LifeMD, Inc. | $151M | 13 | Strong Sell |
| DH | Definitive Healthcare Corp. | $86M | 45 | Hold |
| HCAT | Health Catalyst, Inc. | $120M | 39 | Hold |
| NURS.V | Hydreight Technologies Inc. | $147M | 59 | Hold |
| CARL | Carlsmed, Inc. | $461M | 40 | Hold |
| EVH | Evolent Health, Inc. | $520M | 43 | Hold |
| CCLD | CareCloud, Inc. | $106M | 77 | Buy |
Peer medians: ROE -30.5% · P/E 27.0x · Gross margin 58.1%